New Results

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects

Celine Boschi, David E. Scheim, Audrey Bancod, Muriel Millitello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola
doi: https://doi.org/10.1101/2022.11.24.517882

Article Information

doi 
https://doi.org/10.1101/2022.11.24.517882
History 
  • November 28, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Celine Boschi1,
  2. David E. Scheim2,*,
  3. Audrey Bancod1,
  4. Muriel Millitello1,
  5. Marion Le Bideau1,
  6. Philippe Colson1,
  7. Jacques Fantini3 and
  8. Bernard La Scola1,*
  1. 1MEPHI, Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique - Hôpitaux de Marseille (AP-HM), IHU Méditerranée Infection, 13005 Marseille, France
  2. 2US Public Health Service, Commissioned Officer, Inactive Reserve, Blacksburg, VA 24060, USA
  3. 3INSERM UMR S 1072, Aix-Marseille Université, 13015 Marseille, France
  1. ↵*Correspondence: dscheim{at}alum.mit.edu, Tel.: +1 540 3208013; bernard.la-scola{at}univ-amu.fr, Tel.: +33 413732401
Back to top
Posted November 28, 2022.
Download PDF
Email
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
Celine Boschi, David E. Scheim, Audrey Bancod, Muriel Millitello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola
bioRxiv 2022.11.24.517882; doi: https://doi.org/10.1101/2022.11.24.517882
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area